← Russell 3000 cross-section

MRSH MARSH & MCLENNAN COMPANIES, INC.

Trailing twelve months to 2026-06-30 · as filed 2026-07-21, not restated
Financials

Scale

Market cap
$90.7bn
Revenue TTM
$27.9bn
Net income TTM
$4.0bn
Free cash flow
$4.8bn
Composite score
53.2
Sector rank
#141

Valuation

P / E
22.8
EV / EBITDA
17.1
EV / sales
3.9
FCF yield
5.26%
Earnings yield vs 10-yr
-0.34pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
14.2%
EBITDA margin
22.9%
ROE
25.8%
ROIC
17.6%
Revenue growth
8.3%

Insider activity, last 90 days

Net open-market
$-7.54m
Buyers
0
Sellers
5

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Foreign exchange transaction gains and losses resulting from the conversion of the transaction currency to functional currency are included in operating income in the consolidated statements of income. 13 3. Other revenue included in the consolidated statements of income that is not from contracts with customers is less than 1 % of total revenue and is not presented as a separate line item. Contract assets primarily relate to quota share reinsurance brokerage and contingent insurer revenue. …MARSH & MCLENNAN COMPANIES, INC., 10-Q, period ended 2026-06-30, filed 2026-07-21

Read the full passage →